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Abstract  
Introduction: Breast carcinoma in male is rare accounting less than 1% of all malignancies in men. 
Papillary carcinoma of breast is uncommon but carries a good prognosis. So an accurate diagnosis is 
essential.  
Presentation of case: We report a case of this rare histological type of breast cancer in 48-year-old 
male patient who presented with a large mass in the right breast. Histological examination showed 
features of intracystic invasive papillary carcinoma.  
Conclusion: The intracystic variant of papillary carcinoma is extremely unusual and may be missed on 
cytological examination. A thorough sampling is essential for an accurate diagnosis of invasion in 
these cases. 
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Introduction 
Breast carcinoma in male is rare. It accounts for 0.6% of all breast carcinomas and less than 1% of all 
malignancies in men[1]. Overall survival rates for men with breast carcinoma, stratified by stage of 
disease, are lower than for women with breast carcinoma. However, these differences are most likely due 
to the higher age distribution of male patients and the lower life expectancy of men in the general 
population[1]. Papillary carcinoma is one subtype of breast carcinoma which may be intracystic or 
intraductal and may be invasive or non-invasive. Intracystic papillary carcinoma (IPC) in men is an 
extremely rare condition and represents only 5–7.5% of all male breast carcinomas[2]. Clinical and 
radiological manifestations of intracystic papillary carcinomas are not specific. Pathologic diagnosis can 
be difficult at classical histological examination. Adjuvant therapy is still controversial and prognosis is 
excellent with 10-year survival rate for IPC is 100%; the recurrence-free survival rate is 96% and 77% at 
2 and 10 years, respectively [3]. Here we report a case of this rare histological type of breast cancer in a  
48-year-old male patient with review of literature. 
 
 
Figure 1 Specimen of radical mastectomy showing grayish white solid mass, on cut section having small papillary 
projections. 
Case presentation  
A 48 years old, non-diabetic, hypertensive male patient presented with a swelling in the right breast. The 
swelling was pea sized 9 months ago. Then the swelling gradually increased in size and it was about 8.0 
cm×6.0 cm×6.0cm in measurement at the time of presentation. There was history of watery discharge 
from the nipple of the affected breast with no retraction of nipple. It was not associated with pain, fever or 
weight loss. There was no positive family history. Fine needle aspiration was done from the lesion and 
ductal carcinoma of breast was detected. Then the patient received 4 cycles of chemotherapy and the size 
of the mass decreased. Then right sided radical mastectomy along with axillary clearance was done. 
On gross examination, the breast tissue was 10 cm×7.0 cm×2.5 cm in size and the mass proper, measuring 
7.0 cm×4.0 cm,  was attached with skin and nipple though there were no nipple retraction or skin 
changes (Figure 1). Grossly no margin was involved. Five lymph nodes were found. 
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On histopathological examination, we found atypical epithelial cells arranged in papillary, cribriform as 
well as in solid patterns within a cyst like structure made by thin fibrous strands.  Papillary fronds 
formed by tall columnar cells having uneven stratification and loss of polarity and other atypical cells 
were pleomorphic having hyperchromatic nucleus and loss of polarity. The tumor cells invaded the 
stroma and deeper muscles and there were occasional mitoses (Figure 2, 3). 
 
 
 
 
 
 
 
 
 
 
Figure2 Papillary arrangement of the neoplastic cells within a cyst like space (Hematoxylene and Eosin, 40X) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Papillae lined by atypical columnar cells with stratification and having thin fibrovascular core 
(Hematoxylene and Eosin, 400X). 
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Figure 4Immunihistochemistry showing ER positivity. 
 
 
 
 
 
 
 
 
 
 
Figure 5Immunohistochemistry showing PR positivity. 
On immunohistochemical study the tumor cells were ER and PR positive and HER-2NEU negative 
(Figure 4, 5). 
Discussion 
Intracystic breast carcinoma is rare in females and exceedingly rare in males with a handful of case 
reports in the literature. The Intracystic Papillary Carcinoma (IPC) is more frequently found among 
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postmenopausal woman with an average age between 55 to 67 years [4]. IPC in man is usually reported 
among those of an older age group (67 to 84 years)[2]; However, in our patient, IPC developed 
significantly in younger age. The clinical presentation is similar in both male and female. 
  Papillary carcinoma is of two types: intracystic or intraductal and again it may be invasive or non 
invasive. The traditional term "intracystic papillary carcinoma"(IPC) generally refers to a localized lesion, 
in situ in a cystically dilated duct. Histologically, IPC is divided into 3 subgroups. Pure IPC, IPC 
associated with DCIS, and IPC associated with invasive carcinoma. Given the often marked stromal 
response surrounding these lesions, the distinction between in situ and invasive papillary carcinoma can 
be very difficult to make. Extension of tumor into breast parenchyma and fat beyond the zone of reactive 
changes is the most reliable histological criterion for invasion. This case was diagnosed as IPC associated 
with invasive carcinoma. 
In papillary carcinomas, the fibrovascular stroma is less conspicuous due to the pronounced epithelial 
component; epithelial cells proliferate in a disorderly fashion and have hyperchromatic nuclei, high 
nucleo-cytoplasmic ratio and variable number of mitotic figures [5]. The majority of patients with IPC 
have associated ductal carcinoma in-situ (DCIS), or invasive carcinoma, or both and the treatment 
strategies differ on the basis of this associated pathology.  
The lack of an intact basal myoepithelial cell layer can be identified by calponin, smooth-muscle 
myosin heavy chain (SMM-HC) cytoplasmic stain, and by p63 nuclear stains. This “gold standard” 
method has a relatively high sensitivity and denotes the invasiveness of the tumour cells in malignant 
papillary breast lesions[6]. Though the presence of myoepithelial cells suggests a benign neoplasm, 
occasional myoepithelial cells may be seen in papillary carcinoma and do not negate the diagnosis[7]. 
Triple assessment is essential for diagnosis of IPC in male and it should be done very carefully. In 
mammography IPC presents as a well-defined area but irregular margin suggests invasion[8]. 
Ultrasonography typically reveals a hypoechoic area (representing the cyst) with soft tissue echoes 
projecting from wall of the cyst (intracystic tumour) [9]. Though fine needle aspiration and core biopsies 
are done in these cases, false negativity is very high[10]. Therefore excisional biopsy is suggested in these 
cases. It allows the pathologist to perform histopathological classification with invasion status and 
immunohistochemical study. 
  Though there is no definite guideline for management of IPC in male, Grabowski et al. suggested that 
surgery is the mainstay of treatment, which can be either conservation or mastectomy. Since the prognosis 
of IPC is excellent with low locoregional and distant recurrence rates, mastectomy is usually not 
necessary, unless it is technically unavoidable[11]. There is a controversy regarding axillary lymph node 
clearance. Sentinel node biopsy may be an excellent alternative to full axillary dissection in patients with 
IPC and associated invasive carcinoma [3]. 
    There is no clear indication in adjuvant chemotherapy even in hormone responsive cases. The 
addition of hormonal treatment does not appear to have impacted the outcome [11]. Recently Fayanju et 
al. reviewed that patients having DCIS or microinvasive disease in association with IPC were more likely 
to receive radiotherapy and tamoxifen[12]. 
Conclusion 
Intracystic papillary carcinoma is a very rare entity in male but it has favorable prognosis. Clinical and 
radiological features are not specific and there is a chance of underdiagnosis in aspiration cytology. 
Therefore correct histopathological diagnosis and invasion status is required. The mainstay of treatment is 
surgical resection, with adjuvant therapy if associated to DCIS or invasive carcinoma. 
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